According to public data from the Boao Lecheng International Medical Tourism Pilot Zone, the zone received 863,500 medical tourists in the first nine months of 2026, up 84.59% year on year — including about 10,700 international patients from over 20 countries and regions. Forty-three medical institutions are now based in the zone.
As China's only "medical special zone," Lecheng leverages a special-approved policy to allow clinically needed drugs and devices already approved overseas but not yet in China, drawing growing numbers of Chinese and international patients seeking innovative treatments.
The trend echoes the expansion of international medical pilots in Shanghai, Beijing, and the Greater Bay Area, along with TCM international medical-tourism packages — signaling fast-rising inbound medical travel and cross-border care.
MedBridge focuses on Shanghai's and China's major cities' international hospital network, helping overseas patients access direct-billing hospitals, remote pre-consultation, and medical travel logistics. Treatment plans are determined by the receiving hospital.
(Data source: Boao Lecheng public reports, Oct 2026)

